Nano Packaging
Market Cap
₹85 ₹85.00 Cr.
P/E
3.62
PEG
0.12
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

Thesis goes live on Ahmedabad ramping to high utilization and hitting the targeted group monthly run-rate, with foil volume providing most of the increment at broadly stable realization

Bull path needs earlier Ahmedabad scale-up plus firmer realization and faster ROPP caps and export foil ramp

Bear path follows approval or material delays, softer realization and working-capital stretch that raises funding needs

Key Ratios

Debt to Equity
Debt to Equity
0.57
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
21.97 %
Institutions
Institutions
2.46 %
Market cap
Market cap
85.00 Cr
No. of Shareholders
No. of Shareholders
1,719
OPM (%)
OPM (%)
11.71 %
PE
PE
3.62
Prom Holding
Prom Holding
54.38 %
ROCE (%)
ROCE (%)
47.81
ROE (%)
ROE (%)
30.89
Sales
Sales
303 Cr
  • GSM Foils
  • Ideal TechnoplastInd
  • Matrix Geo Solutions
Last updated on 6 Oct 2026
  • GSM Foils makes blister foil for tablet lidding and higher-gauge strip foil for capsule and tablet packaging. FY25 revenue was ~₹133Cr.
  • It sells to pharma packers, with more than 100 clients by Q1FY27 from 65-70 across 14 states in FY25.
  • Blister foil drives ~65-68% of value and strip foil drives ~30-35%. Earnings move with aluminium pass-through, as aluminium is 80-85% of cost.
  • It caps any single client at 10% and converts orders in 1-2 days. Per management, it prefers fast-conversion foil to higher-margin products with 150-day credit.
  • It is adding pharma caps, an export-focused foil unit, and tube packaging for pharma packs. Management wants foil scale, caps, exports and backward integration.
  • Q2 sales were ~₹48.1Cr after ~₹97Cr in Q1, with September at ₹13.29Cr. The rapid scale-up has stalled after a strong start.
  • Growth consumes working capital. The scale-up needs fresh debt and tight receivables discipline.
  • Near-term profit depends on rebuilding monthly sales to ~₹33-37Cr for ₹400-450Cr FY27 revenue. Management also guides ~₹35Cr PAT.
  • Maharashtra and Gujarat remain its historic core. A 12% promoter sale in Q1FY27 was attributed to personal need.
  • Tube packaging capacity was Q3FY26; no update since
    the guided spend is ₹3-4Cr. It settles whether the project proceeds.
  • Export foil unit was end-Aug 2026; no update since
    the export-focused foil capacity comes online.
  • Additional bank borrowing was ~21 Sep 2026; no update since
    the planned ₹40-50Cr debt funds new foil units toward the FY28 scale ambition.
  • Monthly sales recovery by mid-Nov 2026
    the print shows whether sales recover from August and September lows toward the FY27 guide. It also shows margin.
  • Pharma-cap ramp FY27
    management guides ₹30-35Cr FY27 revenue rising to ₹60-65Cr in FY28.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
61
52W Range
High
294
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

2 No

Negative for this company

4 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on GSM Foils Ltd. Business

GSM Foils is engaged in the business of manufacturing Blister Foils and Aluminium Pharma Foils (Strip Foils) which is used in packaging of pharmaceutical medicines which includes capsules and tablets both. This is a primary packaging material which comes in direct contact with the medicine, hence, utmost care is taken with regards to its quality.

GSM Foils major competitors are SK Offset, S.V.J. Enterprises, Ideal TechnoplastInd, Kaira Can Co, Barflex Polyfilms, Matrix Geo Solutions, Gabriel Pet Straps.
Market Cap of GSM Foils is ₹105 Crs.
While the median market cap of its peers are ₹92 Crs.

GSM Foils seems to be less financially stable compared to its competitors.
Altman Z score of GSM Foils is 4.16 and is ranked 5 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Mar Mar
Conference Call Mar
Conference Call SummaryCon Call Summary

Discussions & Analysis

[]
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material